Business Wire

ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the presentation of abstracts from its ...
Business Wire

Gilead Showcases Latest HIV Pipeline Progress and the Impact of Global Collaboration on Health Equity Efforts at IAS 2023

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming contributions to the 12th International AIDS Society Conference on HIV Science (IAS 2023), ...
Hosted on MSN

AIDS 2026: World Largest Conference On HIV To Hold In Rio de Janeiro, Brazil – IAS

The International AIDS Society (IAS) on Tuesday announced that AIDS 2026, the 26th International AIDS Conference, will take place in Rio de Janeiro, Brazil, and virtually from 25 to 30 July 2026.